Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease
NCT04775732
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
187
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Ulcerative Colitis
Interventions
BIOLOGICAL:
infliximab therapeutic drug monitoring
Sponsor
Imelda GI Clinical Research Center